Smith & Nephew takes on Centerpulse, aims for number one
This article was originally published in Clinica
Executive Summary
"Ultimately we'd like to be number one, but it's a long haul." An ambitious goal, perhaps, but Chris O'Donnell, CEO of the UK's Smith & Nephew, took a big step in the right direction today (March 20) when he announced a £1.5bn ($2.35bn) friendly bid for Swiss rival Centerpulse.